GUERTIN, J.; LELORIER, J.; DURAND, M.; GOW, R.; HOLBROOK, A.; LEVINE, M. IMPACT OF A RESTRICTIVE DRUG ACCESS PROGRAM ON THE RISK OF CARDIOVASCULAR ENCOUNTERS IN CHILDREN EXPOSED TO ADHD MEDICATIONS. Journal of Population Therapeutics and Clinical Pharmacology, [S. l.], v. 21, n. 3, 2018. Disponível em: https://www.jptcp.com/index.php/jptcp/article/view/302. Acesso em: 19 apr. 2024.